SOLVENTUM CORPORATION

Health Issues

-Issues related to regulation of Ethylene Oxide (EtO). -Issues related to access to sterilization capacity for medical technologies. -Medicare and Medicaid payment quality programs and policies, including healthcare associated complications, readmissions, payment bundling, potentially avoidable events, quality outcomes, transparency, health equity, social determinants of health, maternal mortality, risk adjustment, Medicare Advantage, value-based payment policies, and Medicare and Medicaid data. -VA provider coding system modernization. -Implementation of the Patient Protection and Affordable Care Act (PL 111-148). -Implementation of the Helping Hospitals Improve Patient Care Act 21st Century Cures Act (PL 114-255). -Regulations and legislation related to International Classification of Diseases, version 10 (ICD-10). -Healthcare Outcomes Act. -Issues related to the use of Artificial Intelligence. -Issues related to tariffs. -FDA appropriations.

TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Environmental Protection Agency (EPA) · Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid

-Medicare and Medicaid payment quality programs and policies, including healthcare associated complications, readmissions, payment bundling, potentially avoidable events, quality outcomes, transparency, telehealth, health equity, social determinants of health, maternal mortality, risk adjustment, Medicare Advantage, value-based payment policies, and Medicare and Medicaid data. -VA provider coding system modernization. -Implementation of the Patient Protection and Affordable Care Act (PL 111-148). -Implementation of the Helping Hospitals Improve Patient Care Act 21st Century Cures Act (PL 114-255). -Regulations and legislation related to International Classification of Diseases, Version 10 (ICD-10). -Healthcare Outcomes Act. -Issues related to the use of Artificial Intelligence.